Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy

Background: The use of rivaroxaban in clinical practice often deviates from manufacturer prescribing information. No studies have demonstrated an association between this practice and improved outcomes. Methods: We used the RIETE registry to assess the clinical characteristics of patients with pulmo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Pierpaolo Di Micco, Vladimir Rosa Salazar, Carmen Fernandez Capitan, Francesco Dentali, Covadonga Gomez Cuervo, José Luis Fernández Reyes, Jose Antonio Porras, Angeles Fidalgo, Elvira Grandone, Manuel Lopez Meseguer, Manuel Monreal, the RIETE Investigators
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-07-01
Serija:	Life
Teme:	oral anticoagulants DOACs rivaroxaban venpus thromboembolism RIETE
Online dostop:	https://www.mdpi.com/2075-1729/12/8/1128
Oznake:	Označite Brez oznak, prvi označite!